These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17308106)

  • 21. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
    Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
    Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J; Ouyang ZG; Zhang SH; Zhen YS
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.
    Sebens Müerköster S; Rausch AV; Isberner A; Minkenberg J; Blaszczuk E; Witt M; Fölsch UR; Schmitz F; Schäfer H; Arlt A
    Oncogene; 2008 Feb; 27(8):1122-34. PubMed ID: 17704804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
    Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
    Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
    Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc up-regulates NF-kappaB activation via phosphorylation of IkappaB in HUT-78 (Th0) cells.
    Bao B; Prasad AS; Beck FW; Sarkar FH
    FEBS Lett; 2007 Sep; 581(23):4507-11. PubMed ID: 17765898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
    Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling pathway used by HSV-1 to induce NF-kappaB activation: possible role of herpes virus entry receptor A.
    Teresa Sciortino M; Medici MA; Marino-Merlo F; Zaccaria D; Giuffrè M; Venuti A; Grelli S; Mastino A
    Ann N Y Acad Sci; 2007 Jan; 1096():89-96. PubMed ID: 17405920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells.
    Xie W; Wang Y; Huang Y; Yang H; Wang J; Hu Z
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1027-32. PubMed ID: 19141294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells.
    Edelmann J; Klein-Hitpass L; Carpinteiro A; Führer A; Sellmann L; Stilgenbauer S; Dührsen U; Dürig J
    Leuk Res; 2008 Oct; 32(10):1565-72. PubMed ID: 18407351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
    Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of selected phytochemicals and apple extracts on NF-kappaB activation in human breast cancer MCF-7 cells.
    Yoon H; Liu RH
    J Agric Food Chem; 2007 Apr; 55(8):3167-73. PubMed ID: 17373813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
    Oh JH; Kim JH; Ahn HJ; Yoon JH; Yoo SC; Choi DS; Lee IS; Ryu HS; Min CK
    Gynecol Oncol; 2009 Sep; 114(3):509-15. PubMed ID: 19539355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.
    Kawakubo H; Carey JL; Brachtel E; Gupta V; Green JE; Walden PD; Maheswaran S
    Oncogene; 2004 Oct; 23(50):8310-9. PubMed ID: 15378000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An indirect role for oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells.
    Navarro P; Ramkissoon SH; Shah S; Park JM; Murthy RG; Patel SA; Greco SJ; Rameshwar P
    Exp Cell Res; 2012 Dec; 318(20):2604-15. PubMed ID: 22981979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.
    Ahmad A; Banerjee S; Wang Z; Kong D; Sarkar FH
    J Cell Biochem; 2008 Dec; 105(6):1461-71. PubMed ID: 18980240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.
    Barnes GL; Hebert KE; Kamal M; Javed A; Einhorn TA; Lian JB; Stein GS; Gerstenfeld LC
    Cancer Res; 2004 Jul; 64(13):4506-13. PubMed ID: 15231660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: a model of early cancer progression.
    Rao G; Patel PS; Idler SP; Maloof P; Gascon P; Potian JA; Rameshwar P
    Cancer Res; 2004 Apr; 64(8):2874-81. PubMed ID: 15087406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.